Cargando…

Primary Vaginal Non-Hodgkin Lymphoma

Non-Hodgkin lymphoma (NHL) is a type of blood cancer and 25% of NHL patients present with a primary extranodal tumor. Primary NHL of the vagina is extremely rare with only a few cases reported. We present the case of a 79-year-old, grand multipara, Peruvian woman with an eleven-month history of symp...

Descripción completa

Detalles Bibliográficos
Autores principales: Contreras-Chavez, Pamela, Aliaga, Rolig, Samee, Mohammed, Anampa-Guzmán, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373882/
https://www.ncbi.nlm.nih.gov/pubmed/30788202
http://dx.doi.org/10.7759/cureus.3713
_version_ 1783395056071213056
author Contreras-Chavez, Pamela
Aliaga, Rolig
Samee, Mohammed
Anampa-Guzmán, Andrea
author_facet Contreras-Chavez, Pamela
Aliaga, Rolig
Samee, Mohammed
Anampa-Guzmán, Andrea
author_sort Contreras-Chavez, Pamela
collection PubMed
description Non-Hodgkin lymphoma (NHL) is a type of blood cancer and 25% of NHL patients present with a primary extranodal tumor. Primary NHL of the vagina is extremely rare with only a few cases reported. We present the case of a 79-year-old, grand multipara, Peruvian woman with an eleven-month history of symptoms of pelvic and vaginal pain and vaginal bleeding. Vaginal examination revealed an exophytic tumor that involved the labia, right vaginal wall, cervix, parametrium, and pelvic bone. A computed tomography (CT) image showed a 10 x 10 x 9-cm solid tumor in the pelvic cavity with irregular edges in the pelvic floor, parametrium, and the perineal soft tissues. Bilateral pelvic and inguinal adenomegalies were found. No signs of metastases were found. Marrow and bone biopsy studies were negative. The diagnosis was NHL type diffuse large B-cell lymphoma (DLBCL) of vagina stage one. The patient was treated with six courses of CHOP-R (cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab). She showed a complete response and remained in remission in follow-up control visits. NHL of the female genital tract is rare. CHOP-R is the first line of treatment for this type of cancer. However, less is known about the follow-up protocol and relapse management. Vaginal lymphoma has an extremely low prevalence, and collaborative studies are required to study the same.
format Online
Article
Text
id pubmed-6373882
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-63738822019-02-20 Primary Vaginal Non-Hodgkin Lymphoma Contreras-Chavez, Pamela Aliaga, Rolig Samee, Mohammed Anampa-Guzmán, Andrea Cureus Internal Medicine Non-Hodgkin lymphoma (NHL) is a type of blood cancer and 25% of NHL patients present with a primary extranodal tumor. Primary NHL of the vagina is extremely rare with only a few cases reported. We present the case of a 79-year-old, grand multipara, Peruvian woman with an eleven-month history of symptoms of pelvic and vaginal pain and vaginal bleeding. Vaginal examination revealed an exophytic tumor that involved the labia, right vaginal wall, cervix, parametrium, and pelvic bone. A computed tomography (CT) image showed a 10 x 10 x 9-cm solid tumor in the pelvic cavity with irregular edges in the pelvic floor, parametrium, and the perineal soft tissues. Bilateral pelvic and inguinal adenomegalies were found. No signs of metastases were found. Marrow and bone biopsy studies were negative. The diagnosis was NHL type diffuse large B-cell lymphoma (DLBCL) of vagina stage one. The patient was treated with six courses of CHOP-R (cyclophosphamide, doxorubicin, vincristine, prednisone, and rituximab). She showed a complete response and remained in remission in follow-up control visits. NHL of the female genital tract is rare. CHOP-R is the first line of treatment for this type of cancer. However, less is known about the follow-up protocol and relapse management. Vaginal lymphoma has an extremely low prevalence, and collaborative studies are required to study the same. Cureus 2018-12-11 /pmc/articles/PMC6373882/ /pubmed/30788202 http://dx.doi.org/10.7759/cureus.3713 Text en Copyright © 2018, Contreras-Chavez et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Contreras-Chavez, Pamela
Aliaga, Rolig
Samee, Mohammed
Anampa-Guzmán, Andrea
Primary Vaginal Non-Hodgkin Lymphoma
title Primary Vaginal Non-Hodgkin Lymphoma
title_full Primary Vaginal Non-Hodgkin Lymphoma
title_fullStr Primary Vaginal Non-Hodgkin Lymphoma
title_full_unstemmed Primary Vaginal Non-Hodgkin Lymphoma
title_short Primary Vaginal Non-Hodgkin Lymphoma
title_sort primary vaginal non-hodgkin lymphoma
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6373882/
https://www.ncbi.nlm.nih.gov/pubmed/30788202
http://dx.doi.org/10.7759/cureus.3713
work_keys_str_mv AT contreraschavezpamela primaryvaginalnonhodgkinlymphoma
AT aliagarolig primaryvaginalnonhodgkinlymphoma
AT sameemohammed primaryvaginalnonhodgkinlymphoma
AT anampaguzmanandrea primaryvaginalnonhodgkinlymphoma